US0390143032 - Common Stock
RKDA stock results show that Arcadia Biosciences beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Arcadia Biosciences (NASDAQ:RKDA) just reported results for the fourth quarter ...
Arcadia Biosciences (RKDA) stock was trading 6% higher Thursday after it said it was exploring various strategic options, including a possible sale of the company. Read more here.
Arcadia Biosciences (RKDA) disclosed in a Securities and Exchange filing on Monday a prospectus for a secondary offering by its selling stockholders.